These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26099683)
21. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Eren R; Ilan E; Nussbaum O; Lubin I; Terkieltaub D; Arazi Y; Ben-Moshe O; Kitchinzky A; Berr S; Gopher J; Zauberman A; Galun E; Shouval D; Daudi N; Eid A; Jurim O; Magnius LO; Hammas B; Reisner Y; Dagan S Hepatology; 2000 Sep; 32(3):588-96. PubMed ID: 10960454 [TBL] [Abstract][Full Text] [Related]
22. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice. Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317 [TBL] [Abstract][Full Text] [Related]
23. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. Volz T; Allweiss L; Ben MBarek M; Warlich M; Lohse AW; Pollok JM; Alexandrov A; Urban S; Petersen J; Lütgehetmann M; Dandri M J Hepatol; 2013 May; 58(5):861-7. PubMed ID: 23246506 [TBL] [Abstract][Full Text] [Related]
24. Determinants of hepatitis B and delta virus host tropism. Winer BY; Ploss A Curr Opin Virol; 2015 Aug; 13():109-16. PubMed ID: 26164658 [TBL] [Abstract][Full Text] [Related]
25. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection]. Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402 [TBL] [Abstract][Full Text] [Related]
26. Antiviral effect of hepatitis B virus S/C gene loci antisense locked nucleic acid on transgenic mice in vivo. Deng YB; Qin HJ; Luo YH; Liang ZR; Zou JJ Genet Mol Res; 2015 Aug; 14(3):10087-95. PubMed ID: 26345946 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drug study. Xiong Y; Jia Y; Wang H; Liu G; Ren H; Zhuo Z; Zhang D Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):19-21. PubMed ID: 11242128 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. Giersch K; Allweiss L; Volz T; Helbig M; Bierwolf J; Lohse AW; Pollok JM; Petersen J; Dandri M; Lütgehetmann M J Hepatol; 2015 Aug; 63(2):346-53. PubMed ID: 25795587 [TBL] [Abstract][Full Text] [Related]
29. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528 [TBL] [Abstract][Full Text] [Related]
30. Mouse Models of Hepatitis B Virus Pathogenesis. Iannacone M; Guidotti LG Cold Spring Harb Perspect Med; 2015 Aug; 5(11):. PubMed ID: 26292984 [TBL] [Abstract][Full Text] [Related]
31. Mouse models of hepatitis B and delta virus infection. Dandri M; Lütgehetmann M J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647 [TBL] [Abstract][Full Text] [Related]
32. [Hepatitis and hepatocarcinogenesis in the transgenic mice]. Hino O Nihon Rinsho; 1993 Feb; 51(2):531-5. PubMed ID: 8464165 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus immunopathogenesis. Chisari FV; Ferrari C Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225 [TBL] [Abstract][Full Text] [Related]
34. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Ohashi K; Marion PL; Nakai H; Meuse L; Cullen JM; Bordier BB; Schwall R; Greenberg HB; Glenn JS; Kay MA Nat Med; 2000 Mar; 6(3):327-31. PubMed ID: 10700236 [TBL] [Abstract][Full Text] [Related]
35. Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. Ishida Y; Yamasaki C; Yanagi A; Yoshizane Y; Fujikawa K; Watashi K; Abe H; Wakita T; Hayes CN; Chayama K; Tateno C Am J Pathol; 2015 May; 185(5):1275-85. PubMed ID: 25791527 [TBL] [Abstract][Full Text] [Related]
36. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Galun E; Nahor O; Eid A; Jurim O; Rose-John S; Blum HE; Nussbaum O; Ilan E; Daudi N; Shouval D; Reisner Y; Dagan S Virology; 2000 May; 270(2):299-309. PubMed ID: 10792989 [TBL] [Abstract][Full Text] [Related]
37. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293 [TBL] [Abstract][Full Text] [Related]
38. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Uprichard SL; Boyd B; Althage A; Chisari FV Proc Natl Acad Sci U S A; 2005 Jan; 102(3):773-8. PubMed ID: 15640346 [TBL] [Abstract][Full Text] [Related]
39. [Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy]. Li D; Yan YP; Xu DZ; Men K; Zhang JX; Lei XY Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):315-9. PubMed ID: 15938781 [TBL] [Abstract][Full Text] [Related]
40. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection. Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]